Regular readers know we have a jaundiced view of the proliferation of “quality” measurements. Providers suffer from overload, attention may be directed to unimportant areas, and there is a substantial administrative cost in gathering, analyzing and reporting the data. The Institute of Medicine has attempted to address the problem in a new report, Vita Signs: Core Metrics from Health and Health Care Progress. The report is summarized in a Journal of the American Medical Association article. (JAMA Article) The IOM committee responsible for the report was charged with identifying the most useful measures and recommending how they be implemented and maintained over time. They came up 15 “core metrics”, including life expectancy, self-reported health status, obesity, addictive behavior, unintended pregnancy, community health profile–environmental and social factors like parks, education, housing, receipt of preventive services, care access, patient safety, evidence-based care use, care related to patient preferences and goals, spending burden, individual engagement and community engagement. Two quick observations; 15 measures is a lot and these are mostly mush that would require bushels of more specific data points to be gathered. While the IOM committee purported to be concerned about measure fatigue, utility and burden, its report seems to require more of the same–a whole bunch of groups creating a whole bunch of new measures, also probably not well-tested for actual impact on health status and outcomes. The notion of evidence-based medicine alone has led to a proliferation of hundreds of guidelines, and then we get “quality” reporting to ascertain whether the guidelines are being adhered to, at least before they change because new research shows that the old standards of care were wrong. This has happened repeatedly in large disease categories, like hypertension, lipid management and diabetes. And one of the biggest problems from all this quality management is that many providers are simply giving up–taking the reimbursement hit and moving on, doing the best they can for their patients using their professional judgment and experience. One of the best things we could do to advance “quality” would be to de-couple it from reimbursement. Lets do a little contrarian thinking here and ask ourselves whether the whole value-based purchasing notion really makes any sense and has any likelihood of accomplishing its purported goals at a reasonable price.
IOM on Health System Metrics
By Kevin RocheMay 5, 2015Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…